© 2021 Evolve Business Intelligence. All rights reserved. Developed by Nectron
Diagnostics and Biotech
Breast Cancer Liquid Biopsy Market Analysis and Forecast (2021-2028) with COVID Impact Analysis
€ 3,076.07Breast Cancer Liquid Biopsy Market By Circulating Biomarker(Circulating Tumor Cells, Cell-free DNA, Extracellular Vesicles, Others), By End User ( Reference Laboratories, Hospitals and Physician Laboratories) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028
Report Code: EB_LS_312| Page: 156 | Published Date: March 2021
Companion Diagnostics for Oncology Market Analysis and Forecast (2021-2028) with COVID Impact Analysis
€ 3,076.07Companion Diagnostics for Oncology Market by Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Immunohistochemistry (IHC), In situ hybridization (ISH), Fluorescence in situ hybridization (FISH), Others), By Disease Type (Breast Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer, Leukemia, Melanoma, Others), By End-user (Hospital, Pathology/Diagnostic Laboratory, Academic Medical Center, Others) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028
Report Code: EB_LS_1068 | Page: 113 | Published Date: May 2021
HERG Screening Market Analysis and Forecast (2021-2028) with COVID Impact Analysis
€ 3,076.07HERG Screening Market by Type (Mutant KCNH2, Gene KCNH2), By Ion Channel (Voltage Gated, Ligand Gated), By Application (Antiarrhythmic, Antipsychotic, Antibiotics, Others) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028
Report Code: EB_LS_1070 | Page: 115 | Published Date: May 2021
High-Throughput Screening Market Analysis and Forecast (2020-2028) with COVID Impact Analysis
€ 3,076.07High-Throughput Screening Market by Product & Service (Reagents & Assay Kits, Instruments, Consumables & Accessories, Software, Services, Label-free Technology, 3D Cell Culture), By Technology (Cell-based Assays, 2D Cell Culture, Perfusion Cell Culture, Lab-on-a-chip (LOC), Ultrahigh-throughput Screening, Bioinformatics), by Application (Target Identification & Validation, Primary and Secondary Screening, Toxicology Assessment, Others) by End-User (Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations, Others) and by Geography: Global trends, opportunities, and forecast- 2020 to 2028
Report Code: EB_EnP_1198 | Page: 166 | Published Date: July 2021
Human Microbiome Market Analysis and Global Forecast (2020-2028) with COVID Impact Analysis
€ 3,076.07Human Microbiome Market by Product (Prebiotics, Probiotics, Food, Diagnostic Tests, Drugs), Application (Therapeutic, Diagnostic), Disease (Infectious, Metabolic/Endocrine), Research Technology (Genomics, Proteomics, Metabolomics) and by Geography: Global trends, opportunities and forecast- 2020 to 2028
Report Code: EB_LS_1288 | Page: 162 | Published Date: July 2021
Veterinary POC Diagnostic Market Analysis and Forecast (2021-2028) with COVID Impact Analysis
€ 3,076.07Veterinary POC Diagnostic Market By Product (Consumables, Instruments), By Technology (Immunodiagnostics, Clinical Biochemistry, Molecular Diagnostics, Hematology, Urinalysis, Others), By Animal Type (Companion Animals, Livestock Animals), By End Use (Veterinary Clinics, Veterinary Hospitals and Academic Institutes, Home Care Settings) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028
Report Code: EB_LS_1085| Page: 135| Published Date: May 2021